𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pathogenic antibodies to coagulation factors. Part one: Factor VIII and Factor IX

✍ Scribed by P. Lollar

Book ID
109148433
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
228 KB
Volume
2
Category
Article
ISSN
1538-7933

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Activated recombinant human coagulation
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII
✍ Liebman, Howard A.; Chediak, Juan; Fink, Kenneth I.; Galvez, Angel G.; Shah, Pra πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 31 KB πŸ‘ 2 views

Eight patients with inhibitors to factor VIII (4 hemophilia A and 4 nonhemophilic) were treated with recombinant activated factor VII (rFVIIa) to control severe abdominal bleeding. The recombinant factor was supplied under an open-label, emergency-use program to patients previously unresponsive to o

Kinetic parameters of monoclonal antibod
Kinetic parameters of monoclonal antibodies ESH2, ESH4, ESH5, and ESH8 on coagulation factor VIII and their influence on factor VIII activity
✍ C. Egler; T. Albert; O. Brokemper; M. Zabe-KΓΌhn; G. Mayer; J. Oldenburg; R. Schw πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 319 KB

## Abstract The murine monoclonal antibodies ESH2, ESH4, ESH5, and ESH8 specifically bind and inhibit the procoagulant activity of human coagulation factor VIII (FVIII). They are frequently used as a model of inhibitors which are raised against injected FVIII in about 25% of hemophiliacs as a serio